Layered Mineral Matrix for Sequential Growth Factor Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current tissue regeneration systems lack effective temporal control over the release of multiple growth factors, leading to inefficient bone tissue regeneration due to uncontrolled diffusion and limited signaling, and struggle to integrate growth factors into structural matrices while maintaining biological activity.

Innovation Solution

A system with layered mineral matrices, where each layer degrades at a predictable rate, allowing for the controlled release of biomolecules with cell-affecting and matrix-binding properties, ensuring bioactive molecules are released in proximity to cells to stimulate tissue regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If growth factors are delivered by bolus injections or systemic administration, then high levels of growth factors are achieved, but the growth factors diffuse away from the defect site leading to limited local effects and uncontrolled activity at distant sites

Engineering Contradiction:
Improvegrowth factor concentrationVSAvoidlocalized delivery control
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The system segments the delivery of growth factors by using multiple distinct mineral layers (e.g., hydroxyapatite, octacalcium phosphate, beta-tricalcium phosphate) that degrade at different rates. Each layer can be associated with specific biomolecules, allowing spatial and temporal segmentation of growth factor release. This prevents uncontrolled diffusion by localizing growth factors to specific defect sites while maintaining high local concentrations through controlled degradation of individual layers.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system performs preliminary action by pre-associating biomolecules with specific mineral layers before implantation. The mineral layers are designed to degrade at predictable rates, preliminarily controlling when and where growth factors will be released. This preliminary structuring ensures that growth factors remain localized at the defect site and are released in a controlled sequence, preventing both premature diffusion and uncontrolled distant activity.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If growth factors are embedded into plastic microspheres, then localization to defect site is achieved, but structural matrix for tissue ingrowth is not provided and processing into structural matrices is difficult

Engineering Contradiction:
Improvelocalization to defect siteVSAvoidintegration into structural matrix
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The system uses composite materials by combining mineral layers (hydroxyapatite, octacalcium phosphate, beta-tricalcium phosphate) with organic templates and associating biomolecules with these mineral layers. This composite structure provides both the structural matrix needed for tissue ingrowth and the controlled release capability. The mineral layers serve dual functions: providing structural support for tissue integration and controlling growth factor release through their predictable degradation rates, eliminating the need for separate plastic microsphere carriers.

Inventive Principle:
Principle #40Composite materials

3Duration of action of moving object

If multiple growth factors are to be delivered with temporal control, then sequential signaling can be achieved, but existing systems fail to demonstrate ability to temporally deliver multiple growth factors

Engineering Contradiction:
Improvetemporal control of growth factor releaseVSAvoidmulti-layer mineral matrix system
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The system segments temporal delivery by assigning different mineral layers with distinct degradation rates to different growth factors. For example, hydroxyapatite may degrade slowly to provide sustained release of one growth factor, while octacalcium phosphate degrades at an intermediate rate for a second growth factor, and beta-tricalcium phosphate degrades rapidly for a third growth factor. This segmentation achieves sequential temporal control of multiple growth factors without requiring complex external control mechanisms.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system exploits parameter changes in the mineral layers' degradation rates to achieve temporal control. By selecting minerals with inherently different degradation kinetics (hydroxyapatite < octacalcium phosphate < beta-tricalcium phosphate), the system changes the release rate parameter over time. This natural parameter variation allows sequential delivery of multiple growth factors in a predictable temporal sequence, simplifying the overall system complexity compared to externally controlled release mechanisms.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables precise temporal control over growth factor signaling, directing cell activities such as stem cell proliferation and differentiation, enhancing bone tissue regeneration by maintaining biological activity and localized delivery of growth factors.

Implementation Method 1

In use, the plurality of mineral matrices degrade at various predictable rates, facilitating temporal control over release of the biomolecule(s) from the matrices

Methodology Applied
Scientific EffectDissolution:

Data Source

PatentUS9295755B2Multilayer tissue regeneration system
Publication Date: 2016.03.29 WISCONSIN ALUMNI RES FOUND

AI summary

A system for growing tissue based upon layers of an inorganic matrix, wherein each layer of the inorganic matrix is designed to dissolve at a separate rate and result in sequential growth factor delivery upon its dissolution.